Thursday, April 18, 2013

Injex Pharma of Germany has received China SFDA approval to market its needle free injection delivery system for insulin

Injex Pharma of Germany has been granted China SFDA approval to market its INJEX30 needle-free injection system in China. Hangzhou Hema Medical Equipment Co is the exclusive distributor of Injex 30 in China. Injex will sell the product as a needle-free delivery system for insulin
With the INJEX30, the insulin is pushed through a micro-orifice into the superficial skin cells to the tissue below.  This is achieved by using a precise measurement of pressure at a fraction of a second. Use of the INJEX30 needle free injection system is less painful because the skin is penetrated by an extremely fine jet of medication. This is a tremendous help to patients who are uncomfortable or fear the use of traditional needles.

The INJEX30 can be used with all licensed types of insulin. A major advantage of the INJEX30 is its long life.  The injector is made of durable stainless steel and is good for approximately 5,000 injections.  In addition to its small size (96 mm) and weight (75 g), it comes with a 2 year guaranty.

Enter your email address:


Delivered by FeedBurner